Ensysce Biosciences Inc. (ENSC:NASDAQ) shot up at $2.79, a gain of 29.2%. On Wed, Nov 16, 2022, ENSC:NASDAQ touched a New 2-Week High of $2.79. The stock got featured on our News Catalysts scanner on Mon, Nov 14, 2022 at 05:40 PM in the 'EARNINGS' category. From Thu, Nov 03, 2022, the stock recorded 22.22% Up Days and 30.00% Green Days
The stock spiked on Wed, Oct 26, 2022 at $5.2 with a volume of 1M+.
About Ensysce Biosciences Inc. (ENSC:NASDAQ)
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs.
Top 10 Gainers:
- Fast Radius Inc. (FSRD:NASDAQ), 106.29%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 36.33%
- Foresight Autonomous Holdings Ltd. (FRSX:NASDAQ), 33.04%
- XL Group Ltd (XL:NYSE), 30.91%
- Ensysce Biosciences Inc. (ENSC:NASDAQ), 29.17%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
- Creatd Inc. (CRTD:NASDAQ), 22.12%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 21.99%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 19.67%
- Oncorus Inc. (ONCR:NASDAQ), 18.61%